KAI-7535

DRUG2 trials

Sponsors

Kailera

Conditions

ObesityOverweight

Phase 1

A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight

CompletedNCT07294898

KaileraObesity, Overweight

Start: 2025-12-15End: 2026-01-26Updated: 2026-01-29

Phase 2

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

Active, not recruitingNCT07497880

KaileraObesity, Overweight

Start: 2026-04-06End: 2027-07-07Updated: 2026-09-09